Research programme: hepatitis C virus NS5B polymerase inhibitors - IRBM

Drug Profile

Research programme: hepatitis C virus NS5B polymerase inhibitors - IRBM

Alternative Names: HCV NS5B inhibitors - IRBM

Latest Information Update: 24 Mar 2010

Price : $50

At a glance

  • Originator Istituto di Ricerche di Biologia Molecolare
  • Class Indoles; Small molecules
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 24 Mar 2010 Discontinued - Preclinical for Hepatitis C in Italy (PO)
  • 30 Mar 2007 Preclinical trials in Hepatitis C treatment in Italy (unspecified route)
  • 30 Mar 2007 Preclinical data presented at the 233rd American Chemical Society National Meeting (ACS-2007) added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top